Jane Street’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-57,472
| Closed | -$573K | – | 6652 |
|
|
2022
Q4 | $573K | Sell |
57,472
-11,707
| -17% | -$117K | ﹤0.01% | 3238 |
|
|
2022
Q3 | $685K | Buy |
69,179
+12,040
| +21% | +$119K | ﹤0.01% | 3229 |
|
|
2022
Q2 | $560K | Buy |
57,139
+594
| +1% | +$5.82K | ﹤0.01% | 3430 |
|
|
2022
Q1 | $554K | Hold |
56,545
| – | – | ﹤0.01% | 3617 |
|
|
2021
Q4 | $567K | Sell |
56,545
-9
| -0% | -$90 | ﹤0.01% | 3323 |
|
|
2021
Q3 | $565K | Buy |
56,554
+9
| +0% | +$90 | ﹤0.01% | 3302 |
|
|
2021
Q2 | $568K | Buy |
56,545
+6,545
| +13% | +$65.7K | ﹤0.01% | 3283 |
|
|
2021
Q1 | $493K | Buy |
+50,000
| New | +$493K | ﹤0.01% | 3374 |
|